Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
It is the first compound in its class to target both incretin pathways simultaneously
For many eligible patients, they can provide meaningful appetite control and support significant weight loss
Presented for research literature review only Cappa M et al
Standard protocols call for 200-300 mcg twice daily, typically administered subcutaneously near the area of interest
Peptide therapy may offer benefits including but not limited to better sleep, increase in muscle mass, weight loss, increased sex drive, overall improved mood, and a slowed ageing process
It is very important to keep in mind that GLP-1 drugs should not be used simultaneously with other GLP-1 containing products or combined with any other GLP-1 RA
